Blood dialyzer, also known as hemodialyzer or artificial kidney, is a device used to filter blood of a person who is suffering from kidney damage. Hemodialyzer accomplishes extracorporeal removal of waste products such as creatinine, urea, and free water from the blood in states of kidney failure.
.Market Dynamics
Prevalence of kidney diseases is increasing globally, due to rising geriatric population, urinary disorders, and changing lifestyles. For instance in May 2018, According to United Nations, Department of Economic and Social Affairs, Population Division, 55% of the world’s population lived in urban areas, a proportion that is expected to increase to 68% by 2050, the world’s population could add another 2.5 billion people to urban areas by 2050, with close to 90% of this increase taking place in Asia and Africa, which had influenced favourably for sustained growth of the blood dialyzer market over the next decade.
Furthermore, National Kidney Foundation 2021,published a report based on 2018 data which estimated that 1 in 3 adults in the U.S. (approximately 80 million) were at risk for kidney disease. Whereas Kidney disease affects an estimated 37 million people in the U.S. (15% of the adult population; more than 1 in 7 adults). Rising geriatric population and increased prevalence of chronic kidney diseases will lead to increasing demand for blood dialyzers in the global market. For instance, according to the reports published in Centers for Disease Control and Prevention 2021 report, More than 1 in 7, that is 15% of U.S. adults or 37 million people, are estimated to have chronic kidney disease. (CKD), CKD is more common in people aged 65 years or older (38%) than in people aged 45–64 years (12%) or 18–44 years (6%).
Key features of the study:
- This report provides an in-depth analysis of the global blood dialyzer market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 – 2030), considering 2021, as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global blood dialyzer market based on following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include, Baxter International, Inc., Nikkiso Co. Ltd., B. Braun Medical Inc., CVS Health., Nipro Corporation, Diaverum Deutschland GmbH, NxStage Medical, Inc., Fresenius Medical Care AG & Co. KGaA, DaVita Healthcare Partners, Inc., Asahi Kasei Medical Co., Ltd, Browndove Healthcare (F) Ltd, BAIN MEDICAL EQUIPMENT(GUANGZHOU)CO.,LTD, SB-KAWASUMI LABORATORIES, INC, Medtronic, Jihua Medical Apparatus and Instruments Co., Ltd, Allmed Medical Care Holdings Limited and JMS Medical Co.Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global blood dialyzer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global blood dialyzer market
Detailed Segmentation:
- Global Blood Dialyzer Market, By Product Type:
- Global Blood Dialyzer Market, By Dialysis Membrane Material:
- Cellulose Membranes
- Synthetic Membranes
- Global Blood Dialyzer Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Specialty Clinics
- Global Blood Dialyzer Market, By Region:
- North America
- Europe
- By Country
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Baxter International ,
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Nikkiso Co. Ltd.,
- Braun SE,
- CVS Health,
- Nipro Corporation
- Diaverum Deutschland GmbH,
- NxStage Medical, Inc.,
- Fresenius Medical Care AG & Co. KGaA,
- DaVita Healthcare Partners, Inc.,
- Asahi Kasei Medical Co., Ltd,
- Browndove Healthcare (F) Ltd,
- BAIN MEDICAL EQUIPMENT(GUANGZHOU)CO.,LTD,
- SB-KAWASUMI LABORATORIES, INC,
- Medtronic,
- Jihua Medical Apparatus and Instruments Co., Ltd.,
- Allmed Medical Care Holdings Limited.
- JMS Medical Co.Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
